Carey, one of 15 new inductees, was honored at a recent ceremony at the Johns Hopkins School of Medicine. She was recognized for her work with UNC colleagues to identify and tailor treatment for molecular subtypes of breast cancer.
The 521 member society is designed to honor individuals who did their training (in fellowships, postdoctoral training and early faculty positions) at Johns Hopkins and subsequently gained marked distinction elsewhere in their fields of physical, biological, medical, social or engineering sciences or in the humanities.
Carey, a member of the UNC Lineberger Comprehensive Cancer Center, is a medical oncologist dedicated to clinical and translational breast cancer research, which requires a multidisciplinary approach to cancer care to include scientists as well as clinicians.
Carey has authored or co-authored more than 70 manuscripts and book chapters. Currently, she is the principal investigator of a large-scale, multi-institution trial to test new treatments for a basal subtype of breast cancer, and is the principal investigator of a national cooperative group trial examining targeted therapy for another subtype of breast cancer.
Carey earned her medical degree from Johns Hopkins, was a resident in internal medicine and then a fellow in oncology from 1990 to 1997. She earned an advanced degree in clinical research at the Johns Hopkins School of Public Health in 1998, and joined the UNC faculty in 1998.